Synthesis and biological evaluation of ether bridged bicyclic iminosugar derivatives. 2009

Jiun-Ly Chir, and Pey-Jiuann Wu, and Wei Zou, and Milan Bhasin, and Wei-Fu Juang, and Chao-Qi Guo, and An-Tai Wu
Biotechnology Center in Southern Taiwan, Academia Sinica, 2F., No. 22, Lane 31, Sec. 1, Huandong Rd., Sinshih Township, Tainan County 744, Taiwan.

Bicyclic iminosugar derivatives with an ether bridge bearing different substituents on C-2 and the nitrogen atom have been synthesized from a C-glycoside bearing an isopropylidene acetal. The activities of these compounds were investigated against several glycosidase enzymes and showed moderate inhibition and activation.

UI MeSH Term Description Entries
D002417 Cattle Domesticated bovine animals of the genus Bos, usually kept on a farm or ranch and used for the production of meat or dairy products or for heavy labor. Beef Cow,Bos grunniens,Bos indicus,Bos indicus Cattle,Bos taurus,Cow,Cow, Domestic,Dairy Cow,Holstein Cow,Indicine Cattle,Taurine Cattle,Taurus Cattle,Yak,Zebu,Beef Cows,Bos indicus Cattles,Cattle, Bos indicus,Cattle, Indicine,Cattle, Taurine,Cattle, Taurus,Cattles, Bos indicus,Cattles, Indicine,Cattles, Taurine,Cattles, Taurus,Cow, Beef,Cow, Dairy,Cow, Holstein,Cows,Dairy Cows,Domestic Cow,Domestic Cows,Indicine Cattles,Taurine Cattles,Taurus Cattles,Yaks,Zebus
D004789 Enzyme Activation Conversion of an inactive form of an enzyme to one possessing metabolic activity. It includes 1, activation by ions (activators); 2, activation by cofactors (coenzymes); and 3, conversion of an enzyme precursor (proenzyme or zymogen) to an active enzyme. Activation, Enzyme,Activations, Enzyme,Enzyme Activations
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D004987 Ethers Organic compounds having two alkyl or aryl groups bonded to an oxygen atom, as in the formula R1–O–R2.
D006026 Glycoside Hydrolases Any member of the class of enzymes that catalyze the cleavage of the glycosidic linkage of glycosides and the addition of water to the resulting molecules. Endoglycosidase,Exoglycosidase,Glycohydrolase,Glycosidase,Glycosidases,Glycoside Hydrolase,Endoglycosidases,Exoglycosidases,Glycohydrolases,Hydrolase, Glycoside,Hydrolases, Glycoside
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D050111 Imino Sugars Sugars in which the OXYGEN is replaced by a NITROGEN atom. This substitution prevents normal METABOLISM resulting in inhibition of GLYCOSIDASES and GLYCOSYLTRANSFERASES. Sugars, Imino
D019086 Bridged Bicyclo Compounds, Heterocyclic Heterocyclic compounds that contain two rings that share two non-adjacent atoms in common. Bicyclo Compounds, Heterocyclic,Heterocyclic Cpds, Bicyclic,Bicyclic Heterocyclic Compounds,Heterocyclic Bicyclo Compounds,Bicyclic Heterocyclic Cpds,Heterocyclic Compounds, Bicyclic

Related Publications

Jiun-Ly Chir, and Pey-Jiuann Wu, and Wei Zou, and Milan Bhasin, and Wei-Fu Juang, and Chao-Qi Guo, and An-Tai Wu
May 2022, Molecules (Basel, Switzerland),
Jiun-Ly Chir, and Pey-Jiuann Wu, and Wei Zou, and Milan Bhasin, and Wei-Fu Juang, and Chao-Qi Guo, and An-Tai Wu
December 2023, Carbohydrate research,
Jiun-Ly Chir, and Pey-Jiuann Wu, and Wei Zou, and Milan Bhasin, and Wei-Fu Juang, and Chao-Qi Guo, and An-Tai Wu
June 2012, Archiv der Pharmazie,
Jiun-Ly Chir, and Pey-Jiuann Wu, and Wei Zou, and Milan Bhasin, and Wei-Fu Juang, and Chao-Qi Guo, and An-Tai Wu
November 2016, Bioorganic & medicinal chemistry letters,
Jiun-Ly Chir, and Pey-Jiuann Wu, and Wei Zou, and Milan Bhasin, and Wei-Fu Juang, and Chao-Qi Guo, and An-Tai Wu
March 1989, Pharmaceutical research,
Jiun-Ly Chir, and Pey-Jiuann Wu, and Wei Zou, and Milan Bhasin, and Wei-Fu Juang, and Chao-Qi Guo, and An-Tai Wu
February 2003, Bioorganic & medicinal chemistry letters,
Jiun-Ly Chir, and Pey-Jiuann Wu, and Wei Zou, and Milan Bhasin, and Wei-Fu Juang, and Chao-Qi Guo, and An-Tai Wu
June 2003, Journal of medicinal chemistry,
Jiun-Ly Chir, and Pey-Jiuann Wu, and Wei Zou, and Milan Bhasin, and Wei-Fu Juang, and Chao-Qi Guo, and An-Tai Wu
January 2024, Frontiers in pharmacology,
Jiun-Ly Chir, and Pey-Jiuann Wu, and Wei Zou, and Milan Bhasin, and Wei-Fu Juang, and Chao-Qi Guo, and An-Tai Wu
November 2022, Molecules (Basel, Switzerland),
Jiun-Ly Chir, and Pey-Jiuann Wu, and Wei Zou, and Milan Bhasin, and Wei-Fu Juang, and Chao-Qi Guo, and An-Tai Wu
January 2020, Bioorganic chemistry,
Copied contents to your clipboard!